Debt-to-equity of Ocean Biomedical, Inc. from 30 Jun 2022 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ocean Biomedical, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 31 Mar 2025.
  • Ocean Biomedical, Inc. Debt-to-equity for the quarter ending 31 Mar 2025 was -101%, a 2.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Ocean Biomedical, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2025 -101% +2% +2.3% 31 Mar 2025
Q4 2024 -102% +1% +1.3% 31 Dec 2024
Q3 2024 -103% -1% -0.56% 30 Sep 2024
Q2 2024 -103% -4% -3.6% 30 Jun 2024
Q1 2024 -104% -14% -15% 31 Mar 2024
Q4 2023 -103% -37% -57% 31 Dec 2023
Q3 2023 -103% -56% -121% 30 Sep 2023
Q2 2023 -100% -46% -85% 30 Jun 2023
Q1 2023 -90% 31 Mar 2023
Q4 2022 -66% 31 Dec 2022
Q3 2022 -46% 30 Sep 2022
Q2 2022 -54% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.